3/19
09:00 am
alxo
Rating for ALXO
Low
Report
Rating for ALXO
3/19
09:00 am
alxo
Rating for ALXO
Low
Report
Rating for ALXO
3/19
09:00 am
alxo
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
Low
Report
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
3/19
05:53 am
alxo
ALX Oncology initiated with an Overweight at Wells Fargo
Low
Report
ALX Oncology initiated with an Overweight at Wells Fargo
3/19
05:53 am
alxo
ALX Oncology initiated with an Overweight at Wells Fargo
Low
Report
ALX Oncology initiated with an Overweight at Wells Fargo
3/10
08:03 am
alxo
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
3/6
10:58 am
alxo
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
3/6
08:24 am
alxo
ALX Oncology initiated with a Buy at UBS
Medium
Report
ALX Oncology initiated with a Buy at UBS